Patents by Inventor Miho Kato

Miho Kato has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11911420
    Abstract: Provide is a novel prophylactic and/or therapeutic agent for Streptococcus pneumoniae infection. It was found that a bacterium belonging to the genus Enterococcus can prevent and/or treat Streptococcus pneumoniae infection. The prophylactic and/or therapeutic agent for Streptococcus pneumoniae infection, comprises a bacterium belonging to the genus Enterococcus. Also provided are: a medicine for prevention and/or treatment of Streptococcus pneumoniae infection, comprising a bacterium belonging to the genus Enterococcus; and a food for prevention and/or treatment of Streptococcus pneumoniae infection, comprising a bacterium belonging to the genus Enterococcus.
    Type: Grant
    Filed: January 31, 2019
    Date of Patent: February 27, 2024
    Assignee: NUTRI CO., LTD.
    Inventors: Susumu Kawaguchi, Miho Kato
  • Patent number: 11914248
    Abstract: An object of the invention is to provide a photo-alignment copolymer which makes it possible to produce a photo-alignment film having excellent solvent resistance and liquid crystal aligning properties, and a photo-alignment film and an optical laminate produced using the photo-alignment copolymer. A photo-alignment copolymer of the invention is a photo-alignment copolymer having a repeating unit A including a photo-alignment group represented by Formula (A) and a repeating unit B including a crosslinkable group represented by Formula (B).
    Type: Grant
    Filed: November 8, 2020
    Date of Patent: February 27, 2024
    Assignee: FUJIFILM Corporation
    Inventors: Yutaka Nozoe, Takashi Iizumi, Kazushige Nakagawa, Takahiro Kato, Miho Asahi, Hirofumi Omura, Yuki Hirai
  • Publication number: 20230320225
    Abstract: A piezoelectric element includes a piezoelectric body, an external electrode, and an internal electrode. The internal electrode includes first and second internal conductors opposing each other. The first internal conductor includes first and second conductor portions continuous with each other. The second internal conductor includes a third conductor portion opposing the first conductor portion in a direction where the first and second internal conductors oppose each other, and a fourth conductor portion including a first region connected to the second conductor portion, and a second region continuous with the first region and continuous with the third conductor portion. The piezoelectric body includes a body portion located between the first and the second internal conductors, and formed with a through hole penetrating the body portion in the direction. The fourth conductor portion is located in the through hole and has a thickness increasing toward a center line of the through hole.
    Type: Application
    Filed: March 13, 2023
    Publication date: October 5, 2023
    Applicant: TDK Corporation
    Inventors: Hiroki MITSUI, Hideya Sakamoto, Yoshiki Ohta, Miho Kato, Hiroyuki Ijiri, Akihiro Takeda
  • Patent number: 11730776
    Abstract: Provided is a novel prophylactic and/or therapeutic agent for Clostridium difficile infection. It was found that a bacterium belonging to the genus Enterococcus can prevent and/or treat Clostridium difficile infection. The prophylactic and/or therapeutic agent for Clostridium difficile infection, comprising a bacterium belonging to the genus Enterococcus. A medicine for prevention and/or treatment of Clostridium difficile infection, comprising a bacterium belonging to the genus Enterococcus. A food for prevention and/or treatment of Clostridium difficile infection, comprising a bacterium belonging to the genus Enterococcus.
    Type: Grant
    Filed: October 4, 2019
    Date of Patent: August 22, 2023
    Assignee: NUTRI CO., LTD.
    Inventors: Susumu Kawaguchi, Miho Kato
  • Publication number: 20220209096
    Abstract: The vibration device includes a piezoelectric element having a connection terminal exposed from a main surface of the piezoelectric element, a first resin layer having conductivity and covering the connection terminal of the piezoelectric element to be electrically connected to the connection terminal, a wiring member overlapping the main surface of the piezoelectric element to cover the first resin layer, including a wire electrically connected to the first resin layer, and extending beyond one end of the piezoelectric element when viewed in a thickness direction of the piezoelectric element, and a second resin layer integrally covering the main surface of the piezoelectric element and the wiring member. The second resin layer includes a first layer in direct contact with the piezoelectric element and the wiring member, and a second layer covering the piezoelectric element and the wiring member via the first layer.
    Type: Application
    Filed: November 22, 2021
    Publication date: June 30, 2022
    Applicant: TDK CORPORATION
    Inventors: Keisuke TERANISHI, Hiroki MITSUI, Miho KATO, Hideya SAKAMOTO, Narumi SATO
  • Publication number: 20210386797
    Abstract: Provided is a novel prophylactic and/or therapeutic agent for Clostridium difficile infection. It was found that a bacterium belonging to the genus Enterococcus can prevent and/or treat Clostridium difficile infection. The prophylactic and/or therapeutic agent for Clostridium difficile infection, comprising a bacterium belonging to the genus Enterococcus. A medicine for prevention and/or treatment of Clostridium difficile infection, comprising a bacterium belonging to the genus Enterococcus. A food for prevention and/or treatment of Clostridium difficile infection, comprising a bacterium belonging to the genus Enterococcus.
    Type: Application
    Filed: October 4, 2019
    Publication date: December 16, 2021
    Applicant: Nutri Co., Ltd.
    Inventors: Susumu Kawaguchi, Miho Kato
  • Publication number: 20210379124
    Abstract: Provide is a novel prophylactic and/or therapeutic agent for Streptococcus pneumoniae infection. It was found that a bacterium belonging to the genus Enterococcus can prevent and/or treat Streptococcus pneumoniae infection. The prophylactic and/or therapeutic agent for Streptococcus pneumoniae infection, comprises a bacterium belonging to the genus Enterococcus. Also provided are: a medicine for prevention and/or treatment of Streptococcus pneumoniae infection, comprising a bacterium belonging to the genus Enterococcus; and a food for prevention and/or treatment of Streptococcus pneumoniae infection, comprising a bacterium belonging to the genus Enterococcus.
    Type: Application
    Filed: January 31, 2019
    Publication date: December 9, 2021
    Applicant: Nutri Co., Ltd.
    Inventors: Susumu Kawaguchi, Miho Kato
  • Patent number: 10960034
    Abstract: Provided is a novel MRSA infection protective agent. Bacteria belonging to the genus Enterococcus have been found to be capable of protecting against MRSA infection. The MRSA infection protective agent comprises a bacterium belonging to the genus Enterococcus. Also provided are: a medicine for protection against MRSA infection, comprising a bacterium belonging to the genus Enterococcus; and a food for protection against MRSA infection, comprising a bacterium belonging to the genus Enterococcus.
    Type: Grant
    Filed: January 25, 2018
    Date of Patent: March 30, 2021
    Assignee: NUTRI CO., LTD.
    Inventors: Susumu Kawaguchi, Miho Kato
  • Publication number: 20200405784
    Abstract: Provided is a novel prophylactic and/or therapeutic agent for Pseudomonas aeruginosa infection. It was found that a bacterium belonging to the genus Enterococcus can prevent and/or treat Pseudomonas aeruginosa infection. The prophylactic and/or therapeutic agent for Pseudomonas aeruginosa infection, comprising a bacterium belonging to the genus Enterococcus. A medicine for prevention and/or treatment of Pseudomonas aeruginosa infection, comprising a bacterium belonging to the genus Enterococcus. A food for prevention and/or treatment of Pseudomonas aeruginosa infection, comprising a bacterium belonging to the genus Enterococcus.
    Type: Application
    Filed: April 17, 2019
    Publication date: December 31, 2020
    Applicant: Nutri Co., Ltd.
    Inventors: Susumu Kawaguchi, Miho Kato
  • Publication number: 20190374586
    Abstract: Provided is a novel MRSA infection protective agent. Bacteria belonging to the genus Enterococcus have been found to be capable of protecting against MRSA infection, The MRSA infection protective agent comprises a bacterium belonging to the genus Enterococcus. Also provided are: a medicine for protection against MRSA infection, comprising a bacterium belonging to the genus Enterococcus; and a food for protection against MRSA infection, comprising a bacterium belonging to the genus Enterococcus.
    Type: Application
    Filed: January 25, 2018
    Publication date: December 12, 2019
    Applicant: Nutri Co., Ltd.
    Inventors: Susumu KAWAGUCHI, Miho KATO
  • Patent number: 10379832
    Abstract: A device includes a processor that performs a procedure.
    Type: Grant
    Filed: March 9, 2017
    Date of Patent: August 13, 2019
    Assignee: FUJITSU LIMITED
    Inventors: Tomoyuki Onda, Takahisa Hatakeyama, Miho Kato, Kazumi Sasae, Ayano Koike
  • Publication number: 20170262269
    Abstract: A device includes a processor that performs a procedure.
    Type: Application
    Filed: March 9, 2017
    Publication date: September 14, 2017
    Applicant: FUJITSU LIMITED
    Inventors: Tomoyuki Onda, Takahisa Hatakeyama, Miho Kato, KAZUMI SASAE, Ayano Koike
  • Patent number: 9323642
    Abstract: A calculation method includes calculating, by a processor, a difference between a first value and a second value, the first value being read from a clock counter that counts pulses of a clock signal having a plurality of types of frequencies, supplied to the processor in response to control command to start processing for an unit to be allocated to the processor, the second value being read from the clock counter in response to control command to stop processing.
    Type: Grant
    Filed: December 7, 2012
    Date of Patent: April 26, 2016
    Assignee: FUJITSU LIMITED
    Inventors: Miho Kato, Hiroyuki Suzuki, Tsubasa Kitayama, Norio Kurobane
  • Publication number: 20030087949
    Abstract: The invention provides a compound represented by the following formula (I) useful for inhibiting death of cells, the drug being expected as a preventive or a remedy for the progress of various diseases wherein cell death participates in progress and exacerbation thereof: 1
    Type: Application
    Filed: September 26, 2002
    Publication date: May 8, 2003
    Inventors: Mikiko Sodeoka, Miho Kato, Rei Asakai